Erenumab - Amgen/Novartis
At a glance
- Drug Originator Amgen
- Drug Licenced by Amgen; Novartis
- Drug Class Antimigraines; Monoclonal antibodies
- Mechanism of Action Calcitonin gene-related peptide receptor antagonists
- USA Patent Applicants AMGEN INC
- USA Patents 1
- BLAs 1
- International Patents 4
Disclaimer